Close Menu

NEW YORK (GenomeWeb) – ACT Genomics today announced it has raised more than $8 million in its first private funding round.

The funds will support further investment in the firm's lineup of molecular diagnostic assays for monitoring cancer and expansions in the firm's sales, marketing, and medical teams.

"The additional capital will allow us to continue building robust molecular assays and [an] innovative bioinformatics engine," ACT Genomics CEO Hua-Chien Chen said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.